Inhibrx, Inc. (INBX) DCF Valuation

Valoración de DCF de InShibrx, Inc. (INBX)

US | Healthcare | Biotechnology | NASDAQ
Inhibrx, Inc. (INBX) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Inhibrx, Inc. (INBX) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Mejore sus estrategias de inversión con la calculadora DCF de InShibrx, Inc. (INBX)! Explore los datos financieros de Inhibrx auténticos, ajuste las proyecciones y gastos de crecimiento, y observe instantáneamente cómo estas modificaciones afectan el valor intrínseco de InShibrx, Inc. (INBX).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 9.1 12.8 7.1 2.2 1.8 1.4 1.1 .8 .6 .5
Revenue Growth, % 0 40.86 -44.37 -69.43 -17.36 -22.58 -22.58 -22.58 -22.58 -22.58
EBITDA -42.6 -67.4 -76.6 -125.8 -206.7 -1.4 -1.1 -.8 -.6 -.5
EBITDA, % -468.54 -526.57 -1074.58 -5776.72 -11482.94 -100 -100 -100 -100 -100
Depreciation 2.5 2.4 2.7 1.2 1.2 .6 .4 .3 .3 .2
Depreciation, % 27.69 18.68 37.73 56.24 66.17 41.3 41.3 41.3 41.3 41.3
EBIT -45.1 -69.8 -79.3 -127.0 -207.9 -1.4 -1.1 -.8 -.6 -.5
EBIT, % -496.23 -545.25 -1112.31 -5832.97 -11549.11 -100 -100 -100 -100 -100
Total Cash 11.5 128.7 131.3 273.9 277.9 1.4 1.1 .8 .6 .5
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .4 .6 .9 .3 .8
Account Receivables, % 4.82 4.8 12.32 11.8 43.22
Inventories 3.2 -129.3 -.9 -.3 -11.6 -.5 -.4 -.3 -.2 -.2
Inventories, % 35.27 -1009.36 -12.32 -11.8 -644.06 -37.77 -37.77 -37.77 -37.77 -37.77
Accounts Payable 3.1 13.5 9.1 4.3 8.3 1.2 .9 .7 .6 .4
Accounts Payable, % 34.26 105.07 128.07 199.4 461.72 86.85 86.85 86.85 86.85 86.85
Capital Expenditure -1.8 -1.4 -.9 -.7 -4.6 -.5 -.4 -.3 -.2 -.2
Capital Expenditure, % -19.91 -10.65 -12.13 -31.5 -255.17 -34.84 -34.84 -34.84 -34.84 -34.84
Tax Rate, % -0.68287 -0.68287 -0.68287 -0.68287 -0.68287 -0.68287 -0.68287 -0.68287 -0.68287 -0.68287
EBITAT -45.9 -69.8 -79.3 -127.0 -209.3 -1.4 -1.1 -.8 -.6 -.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -45.7 73.8 -210.4 -131.3 -197.9 -18.9 -1.4 -1.0 -.8 -.6
WACC, % 17.37 17.37 17.37 17.37 17.37 17.37 17.37 17.37 17.37 17.37
PV UFCF
SUM PV UFCF -18.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -1
Terminal Value -4
Present Terminal Value -2
Enterprise Value -20
Net Debt -68
Equity Value 47
Diluted Shares Outstanding, MM 47
Equity Value Per Share 1.01

What You Will Get

  • Comprehensive INBX Financials: Access to historical and projected data for precise valuation.
  • Customizable Parameters: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
  • Scenario Analysis: Evaluate various scenarios to assess Inhibrx’s future outlook.
  • User-Friendly Interface: Designed for experts but easy to navigate for newcomers.

Key Features

  • 🔍 Real-Life INBX Financials: Pre-filled historical and projected data for Inhibrx, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Inhibrx’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Inhibrx’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Inhibrx, Inc. (INBX) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Inhibrx, Inc. (INBX)’s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Inhibrx, Inc. (INBX)?

  • Comprehensive Tool: Offers DCF, WACC, and financial ratio analyses tailored for Inhibrx.
  • Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
  • Detailed Insights: Automatically computes Inhibrx’s intrinsic value and Net Present Value.
  • Preloaded Data: Historical and projected data provide reliable benchmarks for analysis.
  • Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on Inhibrx.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Inhibrx, Inc. (INBX) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models for Inhibrx, Inc. (INBX).
  • Consultants: Deliver professional valuation insights on Inhibrx, Inc. (INBX) to clients quickly and accurately.
  • Business Owners: Understand how biotech firms like Inhibrx, Inc. (INBX) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to Inhibrx, Inc. (INBX).

What the Template Contains

  • Pre-Filled DCF Model: Inhibrx, Inc.'s (INBX) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Inhibrx, Inc.'s (INBX) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.